Trilogy Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-189,824
Closed -$32.7M 29
2017
Q2
$32.7M Sell
189,824
-8,783
-4% -$1.43M 1.1% 30
2017
Q1
$32.6M Sell
198,607
-11,864
-6% -$1.97M 1.09% 30
2016
Q4
$30.8M Sell
210,471
-6,726
-3% -$1.01M 1.03% 34
2016
Q3
$36.2M Sell
217,197
-126,550
-37% -$21.4M 1.2% 25
2016
Q2
$52.3M Sell
343,747
-16,618
-5% -$2.58M 1.61% 19
2016
Q1
$54M Sell
360,365
-62,156
-15% -$9.23M 1.49% 22
2015
Q4
$68.6M Sell
422,521
-25,603
-6% -$4.02M 1.78% 15
2015
Q3
$62M Sell
448,124
-82,113
-15% -$12.9M 1.67% 19
2015
Q2
$81.4M Sell
530,237
-3,653
-0.7% -$585K 1.69% 18
2015
Q1
$85.3M Buy
533,890
+97,185
+22% +$15.3M 1.83% 16
2014
Q4
$69.6M Sell
436,705
-57,196
-12% -$8.91M 1.44% 31
2014
Q3
$69.4M Sell
493,901
-189,481
-28% -$24.7M 1.47% 29
2014
Q2
$80.9M Buy
683,382
+127,338
+23% +$14.7M 1.54% 22
2014
Q1
$68.6M Buy
556,044
+287,200
+107% +$34.8M 1.37% 28
2013
Q4
$30.7M Buy
268,844
+42,321
+19% +$4.81M 0.63% 54
2013
Q3
$25.4M Buy
226,523
+12,646
+6% +$1.37M 0.55% 56
2013
Q2
$21.1M Buy
+213,877
New +$22.2M 0.49% 63

Other funds holding AMGN

Trilogy Global Advisors's AMGN Position: Q3 2017 in Review

Trilogy Global Advisors sold out of Amgen (AMGN) in Q3 2017, closing a stake of 189,824 shares — an estimated $32.7M sold.

Trilogy Global Advisors first reported a position in AMGN in Q2 2013 and held it in 17 quarters. The position peaked at $85.3M in Q1 2015. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.

  • Trilogy Global Advisors reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
  • Trilogy Global Advisors sold 189,824 Amgen shares in Q3 2017, an estimated $32.7M.
  • Trilogy Global Advisors first reported a position in Amgen in Q2 2013 and held it in 17 quarters.
  • Trilogy Global Advisors's Amgen position peaked at $85.3M in Q1 2015.
  • 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.

Based on Trilogy Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.